Skip to content
PeptideHormone

Growth-hormone-releasing hormone vs CJC-1295

The hypothalamic signal that tells the pituitary to release GH. A long-acting GHRH analog engineered to stretch GH pulses. Side by side: type, evidence tier, receptor, molecular weight, and half-life — the same fields as each monograph, rearranged so the engineering difference is visible.

Growth-hormone-releasing hormone
GHRH
CJC-1295
Also known as
TypeEndogenousAnalog
EvidenceEstablishedLimited
FamilyGrowth & repairGrowth & repair
ClassHypothalamic releasing peptide (44 aa)GHRH(1-29) analog (with or without a drug-affinity complex)
ReceptorGHRH receptor (GHRHR), a class B GPCRGHRH receptor (GHRHR), a class B GPCR
Molecular weight~5,039.6 Da3,647 Da
Half-life
~7–50 min
Model dosing
~6-8 days (DAC form); ~30 min without DAC
Based onNative hormoneGrowth-hormone-releasing hormone

Half-life bars are on a logarithmic scale across the molecules shown. Reference values for the native or representative form — educational only, not medical or dosing advice.

Common questions

What is the difference between Growth-hormone-releasing hormone and CJC-1295?
Growth-hormone-releasing hormone is an endogenous hormone; CJC-1295 is an engineered analog based on Growth-hormone-releasing hormone. Growth-hormone-releasing hormone signals at GHRH receptor (GHRHR), a class B GPCR; CJC-1295 signals at GHRH receptor (GHRHR), a class B GPCR.
How do the half-lives of GHRH and CJC-1295 compare?
The reported circulating half-life of Growth-hormone-releasing hormone is ~7–50 min; CJC-1295 is ~6-8 days (DAC form); ~30 min without DAC. These are reference values for the native or representative form — educational only, not dosing advice.

Prefer the other order? CJC-1295 vs Growth-hormone-releasing hormone. Or open the interactive comparison tool to add more molecules.